BIOAI – Molecules to Miracles
Biotechnology Research • 
Washington, district of Columbia 20017, United States • 1-10 Employees
Company overview
| Headquarters | Washington, district of Columbia 20017, United States |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
Key Contact at BIOAI – Molecules to Miracles
Kishore Kumar Kavali
Founder & Biotechnology Innovator
About BIOAI – Molecules to Miracles
BIOAI is an AI-powered biotech innovation project founded by a passionate biotechnology student. We’re on a mission to accelerate drug discovery by blending the power of artificial intelligence with molecular biology. From molecule prediction to target validation, BIOAI is exploring how automation, machine learning, and big data can revolutionize early-stage drug development. As we build our journey in public, we aim to share insights, connect with like-minded innovators, and lay the foundation for a next-gen CRDMO (Contract Research, Development & Manufacturing Organization). Join us as we turn molecules into miracles.
BIOAI – Molecules to Miracles revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
BIOAI – Molecules to Miracles has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
BIOAI – Molecules to Miracles has never raised funding before.
United Kingdom
Australia
Frequently asked questions
4.8
40,000 users
